ATE141782T1 - Die anwendung von spinn-akzeptor in einer kosmetischen oder dermatologischen zusammensetzung - Google Patents

Die anwendung von spinn-akzeptor in einer kosmetischen oder dermatologischen zusammensetzung

Info

Publication number
ATE141782T1
ATE141782T1 AT94402979T AT94402979T ATE141782T1 AT E141782 T1 ATE141782 T1 AT E141782T1 AT 94402979 T AT94402979 T AT 94402979T AT 94402979 T AT94402979 T AT 94402979T AT E141782 T1 ATE141782 T1 AT E141782T1
Authority
AT
Austria
Prior art keywords
cosmetic
dermatological composition
spin
skin
acceptor
Prior art date
Application number
AT94402979T
Other languages
English (en)
Inventor
Alain Ribier
Quang Lan Nguyen
Jean-Thierry Simonnet
Boudiaf Boussouira
Original Assignee
Oreal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oreal filed Critical Oreal
Application granted granted Critical
Publication of ATE141782T1 publication Critical patent/ATE141782T1/de

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/14—Liposomes; Vesicles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/15—Oximes (>C=N—O—); Hydrazines (>N—N<); Hydrazones (>N—N=) ; Imines (C—N=C)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers comprising non-phosphatidyl surfactants as bilayer-forming substances, e.g. cationic lipids or non-phosphatidyl liposomes coated or grafted with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/70—Nanostructure
    • Y10S977/778—Nanostructure within specified host or matrix material, e.g. nanocomposite films
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/70—Nanostructure
    • Y10S977/778—Nanostructure within specified host or matrix material, e.g. nanocomposite films
    • Y10S977/78—Possessing fully enclosed nanosized voids or physical holes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/926—Topical chemical, e.g. cosmetic or sunscreen

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nanotechnology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Birds (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Medical Informatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Biotechnology (AREA)
  • Dispersion Chemistry (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT94402979T 1993-12-30 1994-12-21 Die anwendung von spinn-akzeptor in einer kosmetischen oder dermatologischen zusammensetzung ATE141782T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9315869A FR2714604B1 (fr) 1993-12-30 1993-12-30 Utilisation d'un accepteur de spin dans une composition cosmétique ou dermatologique.

Publications (1)

Publication Number Publication Date
ATE141782T1 true ATE141782T1 (de) 1996-09-15

Family

ID=9454572

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94402979T ATE141782T1 (de) 1993-12-30 1994-12-21 Die anwendung von spinn-akzeptor in einer kosmetischen oder dermatologischen zusammensetzung

Country Status (13)

Country Link
US (2) US5569663A (de)
EP (1) EP0665003B1 (de)
JP (1) JP2736312B2 (de)
CN (1) CN1114876A (de)
AT (1) ATE141782T1 (de)
BR (1) BR9405479A (de)
CA (1) CA2138877A1 (de)
DE (1) DE69400431T2 (de)
ES (1) ES2094035T3 (de)
FR (1) FR2714604B1 (de)
HU (1) HUT71385A (de)
PL (1) PL306581A1 (de)
RU (1) RU2139038C1 (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5723502A (en) * 1985-07-18 1998-03-03 Proctor; Peter H. Topical spin trap composition and method
US20050107366A1 (en) * 1991-06-18 2005-05-19 Carney John M. Spin trapping pharmaceutical compositions and methods for use thereof
FR2714604B1 (fr) * 1993-12-30 1996-01-26 Oreal Utilisation d'un accepteur de spin dans une composition cosmétique ou dermatologique.
FR2726762B1 (fr) * 1994-11-10 1997-01-17 Oreal Composition cosmetique ou dermatologique sous forme d'une dispersion d'une phase huileuse dans une phase aqueuse stabilisee a l'aide de particules de gel cubique et son procede d'obtention
WO1997041826A1 (en) * 1996-05-07 1997-11-13 Thomas Jefferson University Use of tempol in the prevention of photoaging
US8039026B1 (en) 1997-07-28 2011-10-18 Johnson & Johnson Consumer Companies, Inc Methods for treating skin pigmentation
US8093293B2 (en) 1998-07-06 2012-01-10 Johnson & Johnson Consumer Companies, Inc. Methods for treating skin conditions
US6750229B2 (en) 1998-07-06 2004-06-15 Johnson & Johnson Consumer Companies, Inc. Methods for treating skin pigmentation
US8106094B2 (en) 1998-07-06 2012-01-31 Johnson & Johnson Consumer Companies, Inc. Compositions and methods for treating skin conditions
CA2377621C (en) * 1999-06-23 2009-05-19 Eric F. Bernstein Use of nitroxides in wound healing and in the prevention of photodamage
US7985404B1 (en) 1999-07-27 2011-07-26 Johnson & Johnson Consumer Companies, Inc. Reducing hair growth, hair follicle and hair shaft size and hair pigmentation
US7309688B2 (en) * 2000-10-27 2007-12-18 Johnson & Johnson Consumer Companies Topical anti-cancer compositions and methods of use thereof
US6743222B2 (en) 1999-12-10 2004-06-01 Candela Corporation Method of treating disorders associated with sebaceous follicles
US20030036749A1 (en) * 1999-12-10 2003-02-20 Durkin Anthony J. Method of treating disorders associated with sebaceous follicles
US20020153508A1 (en) * 2000-06-29 2002-10-24 Lynch Matthew Lawrence Cubic liquid crystalline compositions and methods for their preparation
US8431550B2 (en) 2000-10-27 2013-04-30 Johnson & Johnson Consumer Companies, Inc. Topical anti-cancer compositions and methods of use thereof
US6555143B2 (en) 2001-02-28 2003-04-29 Johnson & Johnson Consumer Products, Inc. Legume products
US7192615B2 (en) 2001-02-28 2007-03-20 J&J Consumer Companies, Inc. Compositions containing legume products
US20030045461A1 (en) * 2001-09-06 2003-03-06 Jen-Chang Hsia Composition and methods of esterified nitroxides gated with carboxylic acids
JP4012058B2 (ja) 2001-12-21 2007-11-21 キヤノン株式会社 リサイクル性重合体、その製造方法、ならびにリサイクル処理方法
FR2846968B1 (fr) * 2002-11-08 2005-02-04 Salles Jean Pierre Nouveaux derives amphiphiles de l'alpha-c-phenyl-n-tert- butyl nitrone
RU2225202C1 (ru) * 2003-02-28 2004-03-10 Бородкина Татьяна Владимировна Гель гигиенический
US20080305055A1 (en) * 2004-12-22 2008-12-11 Werner Baschong Anti-Radical Agents
US20060235370A1 (en) * 2005-04-04 2006-10-19 Oblong John E Method of regulating mammalian keratinous tissue
WO2007048645A2 (en) * 2005-10-24 2007-05-03 Ciba Holding Inc. Protection of oxidizable agents
CN102871857A (zh) * 2005-12-15 2013-01-16 卢塞迪奥·格莱西 新型氮氧化物抗氧化剂的合成和在化妆用和皮肤病用组合物中的使用方法
US8246611B2 (en) 2006-06-14 2012-08-21 Candela Corporation Treatment of skin by spatial modulation of thermal heating
FR2903012A1 (fr) * 2006-06-29 2008-01-04 Arkema France Utilisation d'un polynitroxyde pour lutter contre les desordes cutane lies aux radicaux libres
WO2008008971A1 (en) * 2006-07-13 2008-01-17 Candela Corporation Compact, handheld device for home-based acne treatment
IN2014DN02926A (de) * 2011-11-30 2015-05-15 Angus Chemical
US10660851B2 (en) 2015-01-02 2020-05-26 Rxos Medical Polyfunctional radical scavenger hydrogel formulation

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2408387A2 (fr) * 1975-06-30 1979-06-08 Oreal Compositions a base de dispersions aqueuses de spherules lipidiques
FR2315991A1 (fr) * 1975-06-30 1977-01-28 Oreal Procede de fabrication de dispersions aqueuses de spherules lipidiques et nouvelles compositions correspondantes
DE2745438A1 (de) * 1977-10-08 1979-04-12 Fischer Artur Dr H C Verankerung eines befestigungselementes
JPS5850883A (ja) * 1981-09-21 1983-03-25 Sony Corp 分離フイルタ
US5352442A (en) * 1985-07-18 1994-10-04 Proctor Peter H Topical tempo
US4863717A (en) * 1986-11-10 1989-09-05 The State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of The University Of Oregon Methods for circumventing the problem of free radial reduction associated with the use of stable nitroxide free radicals as contrast agents for magnetic reasonance imaging
US4849346A (en) * 1987-02-12 1989-07-18 Regents Of The University Of Minnesota Method for determining thioredoxin reductase activity
JP2554880B2 (ja) * 1987-05-07 1996-11-20 ポーラ化成工業株式会社 皮膚化粧料
FR2655540B1 (fr) * 1989-12-13 1994-02-11 Oreal Composition cosmetique pour le soin des cheveux et utilisation de ladite composition.
US5334756A (en) * 1991-03-26 1994-08-02 Sandoz Ltd. Carboxylate of certain polyoxyalkylene amines
US5312617A (en) * 1991-05-23 1994-05-17 Unger Evan C Liposoluble compounds useful as magnetic resonance imaging agents
FR2687913A1 (fr) * 1992-02-28 1993-09-03 Oreal Composition pour traitement topique contenant des vesicules lipidiques encapsulant au moins une eau minerale.
FR2714604B1 (fr) * 1993-12-30 1996-01-26 Oreal Utilisation d'un accepteur de spin dans une composition cosmétique ou dermatologique.

Also Published As

Publication number Publication date
JPH07324028A (ja) 1995-12-12
BR9405479A (pt) 1995-09-19
PL306581A1 (en) 1995-07-10
CA2138877A1 (fr) 1995-07-01
RU94045130A (ru) 1996-10-20
DE69400431D1 (de) 1996-10-02
CN1114876A (zh) 1996-01-17
EP0665003A1 (de) 1995-08-02
RU2139038C1 (ru) 1999-10-10
DE69400431T2 (de) 1997-01-16
FR2714604B1 (fr) 1996-01-26
JP2736312B2 (ja) 1998-04-02
HUT71385A (en) 1995-11-28
ES2094035T3 (es) 1997-01-01
EP0665003B1 (de) 1996-08-28
FR2714604A1 (fr) 1995-07-07
US5679691A (en) 1997-10-21
US5569663A (en) 1996-10-29

Similar Documents

Publication Publication Date Title
DE69400431D1 (de) Die Anwendung von Spinn-Akzeptor in einer kosmetischen oder dermatologischen Zusammensetzung
ATE144132T1 (de) Topische schlankheitsmittel enthaltend zwei verschiedenartigen liposomen, sowie anwendung
RU94045258A (ru) Косметическая или дерматологическая композиция для одновременного лечения поверхностных и глубоких слоев кожи и ее применение
AU600738B2 (en) Treatment of keratinous fibres
DE69400337D1 (de) Mittel gegen Hautalterung, das gleichzeitig auf die Hautoberschichten und Tiefschichten wirkt
ATE278378T1 (de) Zusammensetzung für die direktziehende färbung von keratinischen fäsern mit einem direkziehenden kationischen farbstoff und einem polyol und/oder einem polyether
ATE47034T1 (de) Verwendung von nichtwaessrigen wasserstoffperoxidloesungen in kosmetika und therapeutika.
DE3687362D1 (de) Mischungen von fluorenthaltendem polymer, deren herstellung und anwendung.
ATE71831T1 (de) Kosmetische zusammensetzung fuer das haar.
ATE281152T1 (de) Verwendung von glycoglycerolipiden als tenside sowie kosmetische oder dermatologische zubereitungen, solche glycoglycerolipide enthaltend
DE69315927D1 (de) Kosmetische Zusammensetzung, die einen Lipidstoff und eine Hydroxy - oder Ketofettsäure enthält
EP0197358A3 (en) Topical use of 3-phenylacetylamino-2,6-piperidinedione for treatment of skin wrinkles and hyperpigmentation
DE69100920D1 (de) Verfahren zum Färben von Keratinfasern mit 2,4-Diamino-1,3-dimethoxybenzol in einem sauren Medium sowie Mittel zur Durchführung des Verfahrens.
FR2687932B1 (de)
ATE129408T1 (de) Anwendung von feuchtem sucralfatgel als träger für arzneimittel mit topischen aktivitäten und für kosmetische präparate.
ES2193218T3 (es) Combinacion de sustancias activas contra el acne y los comedones inflamados.
ATE60504T1 (de) Dermotrope kosmetische mittel.
ATE102019T1 (de) Mittel zur kosmetischen oder pharmazeutischen verwendung.
ATE168005T1 (de) Verwendung von procystein als depigmentierendes mittel
FI920906A0 (fi) Foerfaranden foer foerebyggande och minskande av aerrskador.
EP0968707A3 (de) Gegen Akne und entzündete Comedonen wirksame Zubereitungen enthaltend Serin-Proteasen und ein oder mehrere Calciumsalze
KR890016124A (ko) 메이컵 화장품용 안료 처리방법
Powers Jr et al. Retinoids: A specific example in dermatotoxicology.
ATE96151T1 (de) Verwendung von hexatrienderivaten zur herstellung von mitteln gegen akne, psoriasis und lichtschaeden der haut.
NL7500493A (en) Hair and scalp conditioner contg. vegetable oils and extracts - for treating serious hair and scalp diseases